161 related articles for article (PubMed ID: 29404439)
21. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
[TBL] [Abstract][Full Text] [Related]
22. HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience.
Clerico M; Dogliotti I; Ghione P; Zilioli VR; Merli F; Botto B; Al Essa W; Battaglini M; Grimaldi D; Cervi L; Ragaini S; Ferrero S; Peri V; De Luca G; Marzano A; Cavallo F
J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207774
[TBL] [Abstract][Full Text] [Related]
23. Clinical Profile and Efficacy of Antivirals in Hepatitis B Virus Reactivation, in Patients With Cancer Receiving Chemotherapy.
Wani MA; Sodhi JS; Yatoo GN; Shah A; Geelani S; Zargar SA; Gulzar GM; Khan M; Aziz SA
J Clin Exp Hepatol; 2020; 10(6):590-598. PubMed ID: 33311896
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study.
Seto WK; Chan TS; Hwang YY; Wong DK; Fung J; Liu KS; Gill H; Lam YF; Lau EHY; Cheung KS; Lie AKW; Lai CL; Kwong YL; Yuen MF
Hepatology; 2017 May; 65(5):1451-1461. PubMed ID: 28027590
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area.
Ko WJ; Chou NK; Hsu RB; Chen YS; Wang SS; Chu SH; Lai MY
J Heart Lung Transplant; 2001 Aug; 20(8):865-75. PubMed ID: 11502409
[TBL] [Abstract][Full Text] [Related]
26. Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation.
Elsebaey MA; Elbedewy TA; Elashry H; Elrefaey W; Elshweikh SA; Elhadidy AA; Shalaby NA; Elsokkary AM; Elashtokhy HEA; Abo-Amer YE; Abo-Elfetoh AR; Hassanien SEA; Fouad A; Abdellatif RS; Ismail AAM
Medicine (Baltimore); 2022 Nov; 101(47):e31962. PubMed ID: 36451458
[TBL] [Abstract][Full Text] [Related]
27. Risk of hepatitis B reactivation in hepatitis B surface antigen seronegative and core antibody seropositive kidney transplant recipients.
Querido S; Weigert A; Adragão T; Rodrigues L; Jorge C; Bruges M; Machado D
Transpl Infect Dis; 2019 Feb; 21(1):e13009. PubMed ID: 30295412
[TBL] [Abstract][Full Text] [Related]
28. Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment.
Nakamoto S; Kanda T; Nakaseko C; Sakaida E; Ohwada C; Takeuchi M; Takeda Y; Mimura N; Iseki T; Wu S; Arai M; Imazeki F; Saito K; Shirasawa H; Yokosuka O
Int J Mol Sci; 2014 Nov; 15(11):21455-67. PubMed ID: 25421241
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis: results from the HEBEM study.
Marzo B; Vidal-Jordana A; Castilló J; Robles-Sanchez MA; Otero-Romero S; Tintore M; Montalban X; Buti M; Riveiro-Barciela M
J Neurol; 2024 Jan; 271(1):134-140. PubMed ID: 37695530
[TBL] [Abstract][Full Text] [Related]
30. High Risk of Viral Reactivation in Hepatitis B Patients with Systemic Lupus Erythematosus.
Chen MH; Wu CS; Chen MH; Tsai CY; Lee FY; Huang YH
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502025
[TBL] [Abstract][Full Text] [Related]
31. Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation.
Wu Y; Huang H; Luo Y
Front Immunol; 2020; 11():610500. PubMed ID: 33613534
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country.
Murt A; Elverdi T; Eskazan AE; Salihoglu A; Ar MC; Ongoren S; Baslar Z; Soysal T
Ann Hematol; 2020 Nov; 99(11):2671-2677. PubMed ID: 32737632
[TBL] [Abstract][Full Text] [Related]
33. The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-Analysis.
Ko PH; Kuo MH; Kao IT; Wu CY; Tseng CW; Shao SC
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257778
[TBL] [Abstract][Full Text] [Related]
34. Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.
Loss GE; Mason AL; Blazek J; Dick D; Lipscomb J; Guo L; Perrillo RP; Eason JD
Clin Transplant; 2001; 15 Suppl 6():55-8. PubMed ID: 11903388
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B Virus Reactivation upon Immunosuppression: Is There a Role for Hepatitis B Core-Related Antigen in Patients with Immune-Escape Mutants? A Case Report.
Caviglia GP; Zorzi A; Rizzetto M; Mirandola M; Olivero A; Carolo G
Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943420
[TBL] [Abstract][Full Text] [Related]
36. Stratified management based on surface antibody for the prevention of hepatitis B virus reactivation in lymphoma patients.
Liu H; He Z; Gui R; Guo J; Chen L; Zhong M; Li J; Cao L; Fan L
Br J Haematol; 2023 Nov; 203(4):571-580. PubMed ID: 37803485
[TBL] [Abstract][Full Text] [Related]
37.
Bedi HK; Trasolini R; Lowe CF; Hussaini T; Bigham M; Ritchie G; Yoshida EM
Hepatol Forum; 2021 Sep; 2(3):117-119. PubMed ID: 35784901
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus reactivation in hepatocellular carcinoma patients after hepatic arterial infusion chemotherapy combined with and without immunotherapy.
Zhang L; Liu Y; Song S; Makamure J; Shi H; Zheng C; Liang B
Infect Agent Cancer; 2024 Apr; 19(1):19. PubMed ID: 38693564
[TBL] [Abstract][Full Text] [Related]
39. Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial.
Cheng PN; Liu CJ; Chen CY; Tseng KC; Lo CC; Peng CY; Lin CL; Chiu HC; Chiu YC; Chen PJ
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2800-2808. PubMed ID: 34864158
[TBL] [Abstract][Full Text] [Related]
40. Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study.
Yi JH; Lee JL; Lee YJ; Kang HJ; Park YH; Yuh YJ; Lim SN; Kim HJ; Jung SH; Lee JJ; Cho HJ; Moon JH; Yhim HY; Kim K
Clin Lymphoma Myeloma Leuk; 2024 Feb; 24(2):e50-e57.e2. PubMed ID: 37973459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
